跳至主要内容
临床试验/NL-OMON20316
NL-OMON20316招募中不适用

Targeting the secondary bile acid glycodeoxycholic acid as therapeutic strategy in type 2 diabetes mellitus.

Academic Medical Center (AMC), Amsterdam, The Nettherlands0 个研究点目标入组 40 人开始时间: 待定最近更新:

试验速览

阶段
不适用
状态
招募中
发起方
入组人数
40

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • In order to be eligible to participate in this study, a subject must meet all of the following criteria:

排除标准

  • Use of medication that interferes with BA metabolism (colesevelam, colestimide, ursodeoxycholic acid).
  • Diabetes treatment with dipeptidyl peptidase-4 inhibitors, GLP-1 receptor agonists or insulin

研究者

发起方
Academic Medical Center (AMC), Amsterdam, The Nettherlands

相似试验